Tsumuar plans to enter into China market
date:2020-02-07
browse:(1143)
Keyword: Tsumuar ,China market
On February 3, Tsumuar, Japan Chinese medicine enterprises, announced that it was spending 16 billion yuan on a state-of-the-art new factory, plan to start production in April. The company also plans to open a new plant in Tianjin, China, in 2022, which will first produce Chinese medicine for Japan, and in the future it will also produce goods for China.
The company is considering a full entry into the Chinese market and aims to achieve a total of 10 billion yuan in sales in China by 2017. At present, Tsumuar has partnered with Ping An of China, and the company will also import Chinese AI technology for production.
Source: Sina
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year